Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REPHA-OS Mundspray
- Development stage
- Unknown
- Lead developer
- Repha
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
REPHA-OS Mundspray is a plant-based oral and throat spray developed and marketed by the German family-owned company Repha GmbH. It is formulated as a combination of seven medicinal plant extracts and essential oils, including myrrh, tormentill root (bloodroot), ratanhia root, peppermint oil, eucalyptus oil, clove oil, and anise oil, supplemented with menthol. The product exerts antimicrobial and antibacterial effects, making it suitable for the supportive treatment of inflammatory conditions in the mouth and throat, such as gingivitis, stomatitis, and halitosis (bad breath). It is also used preventatively during the cold season to support oral hygiene. The formulation is sugar-free (sweetened with stevia), vegan, and free from chlorhexidine, which avoids the common side effect of tooth discoloration. It is approved and marketed in Germany as an over-the-counter product available in pharmacies.
- Brand names
- REPHA-OS MundsprayREPHA-OS
- Other names
- REPHA-OS mouth spray
Beyond the preview
Go deeper on REPHA-OS Mundspray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REPHA-OS Mundspray.